Published on March 21st, 20130
Doctor-Industry Financial Connections Revealed
Under a provision of the Patient Protection and Affordable Health Care Act (ACA), consumers can view the database, which will shed light on financial ties between drug and device manufacturers and health care providers. The provision, known as the Physician Payment Sunshine Act, grew out of the government’s desire to enforce anti-kickback statutes and reveal conflicts of interests between doctors and the medical industry.
Last winter, the Centers for Medicare & Medicaid Services (CMS), a division of the U.S. Department of Health and Human Services that is overseeing the regulations, finalized rules for the provision, but consumers won’t see the benefits until next year when the information has to be disclosed to the public.
Who’s covered under the rules?
The rule requires that manufacturers of drugs, medical devices and medical supplies covered by Medicare, Medicaid, or the Children’s Health Insurance Program report financial payments for meals, travel, entertainment, royalties, licenses, gifts, research, or education provided to physicians or hospitals. The government can fine companies up to $1 million if the payments aren’t disclosed.
Companies don’t have to reveal payments under $10, product samples, education materials provided to patients, loans of covered devices during trial periods, or discounts.
Why are these regulations important to consumers?
Laws already on the books prevent physicians from prescribing a drug or recommending a particular medical device if the physician or close family member has a vested financial interest in the company making the products. Advocates for the regulations say the rules will help prevent medical companies from concealing ties with medical providers, help reduce conflicts of interest, and empower consumers to make informed decisions about products they are being advised to use.
Said Peter Budetti, a doctor and deputy administrator for CMS,
You should know when your doctor has a financial relationship with the companies that manufacture or supply the medicines or medical devices you may need. Disclosure of these relationships allows patients to have more informed discussions with their doctors.
This story was updated on 9/30/2014.